AU2001235506A1 - Dermatological use and a dermatological preparation - Google Patents

Dermatological use and a dermatological preparation

Info

Publication number
AU2001235506A1
AU2001235506A1 AU2001235506A AU3550601A AU2001235506A1 AU 2001235506 A1 AU2001235506 A1 AU 2001235506A1 AU 2001235506 A AU2001235506 A AU 2001235506A AU 3550601 A AU3550601 A AU 3550601A AU 2001235506 A1 AU2001235506 A1 AU 2001235506A1
Authority
AU
Australia
Prior art keywords
dermatological
preparation
dermatological preparation
dermatological use
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001235506A
Other languages
English (en)
Inventor
Pekka Heino
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ipsat Therapies Oy
Original Assignee
Ipsat Therapies Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ipsat Therapies Oy filed Critical Ipsat Therapies Oy
Publication of AU2001235506A1 publication Critical patent/AU2001235506A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
    • A61P5/16—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4 for decreasing, blocking or antagonising the activity of the thyroid hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Diabetes (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
AU2001235506A 2000-04-06 2001-02-05 Dermatological use and a dermatological preparation Abandoned AU2001235506A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FI20000818 2000-04-06
FI20000818A FI107018B (fi) 2000-04-06 2000-04-06 Dermatologinen käyttö ja valmiste
PCT/FI2001/000100 WO2001076589A1 (en) 2000-04-06 2001-02-05 Dermatological use and a dermatological preparation

Publications (1)

Publication Number Publication Date
AU2001235506A1 true AU2001235506A1 (en) 2001-10-23

Family

ID=8558139

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001235506A Abandoned AU2001235506A1 (en) 2000-04-06 2001-02-05 Dermatological use and a dermatological preparation

Country Status (14)

Country Link
US (2) US20030144359A1 (enExample)
EP (1) EP1274416A1 (enExample)
JP (1) JP2003530349A (enExample)
AU (1) AU2001235506A1 (enExample)
CA (1) CA2405425A1 (enExample)
CH (1) CH695983A5 (enExample)
DE (1) DE10196025T1 (enExample)
DK (1) DK200201483A (enExample)
ES (1) ES2193003B1 (enExample)
FI (1) FI107018B (enExample)
GB (1) GB2377380B (enExample)
NO (1) NO20024810L (enExample)
SE (1) SE0202886L (enExample)
WO (1) WO2001076589A1 (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11508241A (ja) * 1995-06-07 1999-07-21 カロ バイオ エービー 甲状腺ホルモンまたは甲状腺ホルモン様化合物に関する新規な使用
US8668926B1 (en) 2003-09-15 2014-03-11 Shaker A. Mousa Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists, and formulations thereof
US9198887B2 (en) 2003-09-15 2015-12-01 Nanopharmaceuticals Llc Thyroid hormone analogs and methods of use
AU2004273986B2 (en) * 2003-09-15 2010-04-22 Nanopharmaceuticals Llc Thyroid hormone analogs and methods of use in angiogenesis
US9498536B2 (en) 2005-09-15 2016-11-22 Nanopharmaceuticals Llc Method and composition of thyroid hormone analogues and nanoformulations thereof for treating anti-inflammatory disorders
US10130686B2 (en) 2005-09-15 2018-11-20 Nanopharmaceuticals Llc Method and composition of thyroid hormone analogues and nanoformulations thereof for treating inflammatory disorders
WO2007035612A2 (en) 2005-09-16 2007-03-29 Ordway Research Institute, Inc. Polyphenol conjugates as rgd-binding compounds and methods of use
EP2120913B1 (en) 2006-12-22 2015-01-21 NanoPharmaceuticals LLC Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists, and formulations and uses thereof
WO2010075332A1 (en) * 2008-12-23 2010-07-01 Charitable Leadership Foundation Small molecule ligands of the integrin rgd recognition site and methods of use
US9180107B2 (en) 2009-03-31 2015-11-10 Nanopharmaceuticals Llc Combination treatment of cancer with cetuximab and tetrac
WO2010148007A2 (en) 2009-06-17 2010-12-23 Ordway Research Institute, Inc. Nanoparticle and polymer formulations for thyroid hormone, analogs, antagonists, and formulations and uses thereof
US8802240B2 (en) 2011-01-06 2014-08-12 Nanopharmaceuticals Llc Uses of formulations of thyroid hormone analogs and nanoparticulate forms thereof to increase chemosensitivity and radiosensitivity in tumor or cancer cells
AU2017279536A1 (en) 2016-06-07 2018-12-20 Nanopharmaceuticals, Llc Non-cleavable polymer conjugated with αvβ3 integrin thyroid antagonists
US10328043B1 (en) 2018-04-11 2019-06-25 Nanopharmaceuticals, Llc. Composition and method for dual targeting in treatment of neuroendocrine tumors
US11351137B2 (en) 2018-04-11 2022-06-07 Nanopharmaceuticals Llc Composition and method for dual targeting in treatment of neuroendocrine tumors
US10961204B1 (en) 2020-04-29 2021-03-30 Nanopharmaceuticals Llc Composition of scalable thyrointegrin antagonists with improved blood brain barrier penetration and retention into brain tumors
US11723888B2 (en) 2021-12-09 2023-08-15 Nanopharmaceuticals Llc Polymer conjugated thyrointegrin antagonists

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB859546A (en) * 1956-05-29 1961-01-25 Arthur Alfred Hellbaum Composition for treatment of the skin
US3198702A (en) * 1960-03-17 1965-08-03 Arthur A Hellbaum Method for treating skin burns
CA2184002A1 (en) * 1994-02-23 1995-08-31 Jeffrey M. Blaney Method and compositions for increasing the serum half-life of pharmacologically active agents
JPH11508241A (ja) * 1995-06-07 1999-07-21 カロ バイオ エービー 甲状腺ホルモンまたは甲状腺ホルモン様化合物に関する新規な使用
US6380255B1 (en) * 1995-06-07 2002-04-30 Karo Bio Ab Treatment for dermal skin atrophy using thyroid hormone compounds or thyroid hormone-like compounds
HUT75956A (en) * 1995-11-29 1997-05-28 Cyclolab Pharmaceutical composition containing thyroxine
US5951989A (en) * 1997-04-07 1999-09-14 Heymann; Warren R. Method for the treatment of dry skin
GB9828442D0 (en) * 1998-12-24 1999-02-17 Karobio Ab Novel thyroid receptor ligands and method II
AU780503B2 (en) * 1999-04-26 2005-03-24 Albert Burger Pharmaceutical compositions of tetrac and methods of use thereof
US6716877B2 (en) * 2001-01-31 2004-04-06 The Arizona Board Of Regents On Behalf Of The University Of Arizona Method to treat chronic heart failure and/or elevated cholesterol levels

Also Published As

Publication number Publication date
DE10196025T1 (de) 2003-03-13
EP1274416A1 (en) 2003-01-15
SE0202886D0 (sv) 2002-10-01
FI20000818A0 (fi) 2000-04-06
NO20024810L (no) 2002-12-06
GB2377380B (en) 2004-07-14
US20030144359A1 (en) 2003-07-31
DK200201483A (da) 2002-10-03
ES2193003A1 (es) 2003-10-16
CA2405425A1 (en) 2001-10-18
GB0222880D0 (en) 2002-11-13
US20050272817A1 (en) 2005-12-08
CH695983A5 (de) 2006-11-15
SE0202886L (sv) 2002-12-02
WO2001076589A1 (en) 2001-10-18
GB2377380A (en) 2003-01-15
NO20024810D0 (no) 2002-10-04
ES2193003B1 (es) 2005-02-01
FI107018B (fi) 2001-05-31
JP2003530349A (ja) 2003-10-14

Similar Documents

Publication Publication Date Title
AU2002235128A1 (en) Expression miniarrays and uses thereof
AU2001264258A1 (en) Nonwoven-fabric laminate and use thereof
GB2377380B (en) Dermatological use and a dermatological preparation
AU2002211717A1 (en) Stresscopins and their uses
AU2001283344A1 (en) Dermatological formulation
AU2001261750A1 (en) Laminate and its use
AU2001292936A1 (en) Octahydro-indolizines and quinolizines and hexahydro-pyrrolizines
AU7458201A (en) Laminate and use thereof
AU2001295185A1 (en) Multiplexing-interleaving and demultiplexing-deinterleaving
AU2001271732A1 (en) 25869, a human carboxylesterase and uses thereof
AU2002227925A1 (en) Human beta-defensin-3
AU2001252062A1 (en) Steatosis-modulating factors and uses thereof
AU4432001A (en) Trityl-type compounds and their use
AU2001252921A1 (en) A glycopeptide and preparation thereof
AU2001268440A1 (en) 53320, a human acyltransferase and uses therefor
AU2001277519A1 (en) Bio-probes and use thereof
AU2001243447A1 (en) 16835, a human phospholipase c and uses thereof
AU2001252621A1 (en) Novel proetin and use thereof
AU2002211365A1 (en) 22437, a human sulfatase and uses therefor
AU2001268435A1 (en) 23680, a novel human aminotransferase and uses therefor
AU2001291221A1 (en) 55063, a human nmda family member and uses thereof
AU2001296325A1 (en) 47647, a human lipase and uses therefor
AU2002232644A1 (en) 53010, a human carboxylesterase family member and uses thereof
AU2001276025A1 (en) 25233, a human aminotransferase and uses therefor
AU2001283321A1 (en) A human phospholipase c and uses thereof